Share

Weak earnings, Trump fears pressure US stocks

New York - The Dow retreated Tuesday as US stocks remained pressured following lacklustre earnings from ExxonMobil and uncertainty over the Trump growth agenda.

ExxonMobil missed expectations and shares fell 1.2% after the company reported a 39.6% drop in fourth-quarter earnings to $1.7bn.

Among those that dropped more than 1% were JPMorgan Chase, Goldman Sachs and Caterpillar, blue-chip companies that had rallied after President Donald Trump's election sparked hopes of tax cuts, infrastructure spending and other growth policies.

Analysts said there is greater skepticism that Trump and congressional Republicans will succeed in enacting their agenda following a stream of controversies in the administration's early days, most recently over the executive order on immigration.

The Dow Jones Industrial Average ended at 19 864.09, down 0.5% and pulling back further from the historic 20 000 points level and the lowest in a week.

The broad-based S&P 500 slipped 0.1% to 2 278.87, while the tech-rich Nasdaq Composite Index finished up a hair at 5 614.79

"It's a combination of disappointing earnings, Trump worries and macro news," said Peter Cardillo, chief market economist at First Standard Financial.

UPS slumped 6.8% as it reported a loss of $239m in the fourth quarter and projected weaker-than-expected 2017 profits due in part to ramped-up capital investments to improve e-commerce business.

Sports apparel and Shoe Company Under Armour plunged 23.4% after reporting earnings that missed expectations, and the departure of chief financial officer Chip Molloy due to personal reasons.

Harley-Davidson lost 1.5% after offering a gloomy forecast due to sluggish demand in the United States.

Deliveries slumped 12% in the fourth quarter.

Pharmaceutical shares were mostly higher after a White House meeting of top executives with Trump, who reiterated a pledge to lower drug prices, but also said he would work to slash regulations to streamline the drug-approval process.

Merck rose 0.9%, Amgen 1.5% and Mylan 3.3%.

Investors were looking ahead to an earnings release later on Tuesday from Apple, and to Wednesday's finale to a Federal Reserve monetary policy meeting.

Read Fin24's top stories trending on Twitter:

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Rand - Dollar
19.02
-0.6%
Rand - Pound
24.01
-0.5%
Rand - Euro
20.52
-0.3%
Rand - Aus dollar
12.35
+0.0%
Rand - Yen
0.13
-0.6%
Platinum
900.40
+0.4%
Palladium
998.40
-0.3%
Gold
2,211.77
+0.8%
Silver
24.64
-0.0%
Brent Crude
86.09
-0.2%
Top 40
68,114
+0.6%
All Share
74,310
+0.5%
Resource 10
56,946
+2.3%
Industrial 25
103,653
+0.4%
Financial 15
16,467
-0.3%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE
Government tenders

Find public sector tender opportunities in South Africa here.

Government tenders
This portal provides access to information on all tenders made by all public sector organisations in all spheres of government.
Browse tenders